Hasmonian Consultants advises companies that are approaching near-term revenue, on obtaining non-dilutive financing to grow their business. Such funding should be used to support pre-revenue OPEX and/or CAPEX requirements.
Although sector agnostic, we have a core competency in advising companies in mining, energy, health care and technology. An example of this would be a mining company that has substantially completed its various studies and permitting, and is ready to build out its mining operations.
Hasmonian specializes in advising companies on how to obtain such non-dilutive loans, which would be paid back by the revenue stream generated by operations. This allows founders to continue to hold a larger equity position.
In summary, we offer our advice to any company involved in an infrastructure project and concerned with ESG, that has a near term predictable revenue stream (couple of years), and is able to repay the loan over several years.
Principal
Solomon (Sam) Pillersdorf
Dr. Pillersdorf has been involved in various facets of business, having accumulated a broad base of experience as a successful investor and entrepreneur. He has retired from a successful medical practice where he was the Head of the Outpatient Rheumatology Clinic and Head of Rheumatology Training at the McMaster University Medical Centre. He is President of companies that are involved in commercial real estate, technology, agriculture, securities investments, and start-up venture opportunities. He runs his family’s investment office.
Dr Pillersdorf is a Cofounder and Director of tilr Corporation, a company that matches job seekers with employment, based on skills. He has invested in, and has been a director of, several technology startups.
He has been involved in the natural resources sector for many years, in different capacities. He has been an intermediary facilitating the sale of early mining projects to larger companies. He has been a founder, director of, and investor in, many junior mining companies.
He is the Chief Medical and Science Officer of PlanTEXT Ltd., a company pioneering the use of cannabis derived or related compounds to treat various forms of addiction and inflammatory diseases.